Schmidt-Erfurth U - Search Results

1

Correlation of OCT characteristics and retinal sensitivity in neovascular age-related macular degeneration in the course of monthly ranibizumab treatment.

Sulzbacher F, Kiss C, Kaider A, Roberts P, Munk M, Kroh ME, Sayegh R, Schmidt-Erfurth U. Sulzbacher F, et al. Invest Ophthalmol Vis Sci. 2013 Feb 1;54(2):1310-5. doi: 10.1167/iovs.12-11046. Invest Ophthalmol Vis Sci. 2013. PMID: 23349430 Clinical Trial.

2

Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration.

Ergun E, Maár N, Radner W, Barbazetto I, Schmidt-Erfurth U, Stur M. Ergun E, et al. Ophthalmology. 2003 Jan;110(1):65-9. doi: 10.1016/s0161-6420(02)01566-x. Ophthalmology. 2003. PMID: 12511348 Clinical Trial.

3

Effects of verteporfin therapy on central visual field function.

Schmidt-Erfurth UM, Elsner H, Terai N, Benecke A, Dahmen G, Michels SM. Schmidt-Erfurth UM, et al. Ophthalmology. 2004 May;111(5):931-9. doi: 10.1016/j.ophtha.2003.12.025. Ophthalmology. 2004. PMID: 15121371 Clinical Trial.

4

Comparison of the original Amsler grid with the modified Amsler grid: result for patients with age-related macular degeneration.

Augustin AJ, Offermann I, Lutz J, Schmidt-Erfurth U, Tornambe P. Augustin AJ, et al. Retina. 2005 Jun;25(4):443-5. doi: 10.1097/00006982-200506000-00008. Retina. 2005. PMID: 15933590

5

Anecortave acetate for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.

Schmidt-Erfurth U, Michels S, Michels R, Aue A. Schmidt-Erfurth U, et al. Eur J Ophthalmol. 2005 Jul-Aug;15(4):482-5. doi: 10.1177/112067210501500411. Eur J Ophthalmol. 2005. PMID: 16001382 Clinical Trial.

6

Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases.

Schmidt-Erfurth U, Leitgeb RA, Michels S, Povazay B, Sacu S, Hermann B, Ahlers C, Sattmann H, Scholda C, Fercher AF, Drexler W. Schmidt-Erfurth U, et al. Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3393-402. doi: 10.1167/iovs.05-0370. Invest Ophthalmol Vis Sci. 2005. PMID: 16123444

7

Comparison of early retreatment with the standard regimen in verteporfin therapy of neovascular age-related macular degeneration.

Michels S, Wachtlin J, Gamulescu MA, Heimann H, Prünte C, Inhoffen W, Krebs I, Schmidt-Erfurth U. Michels S, et al. Ophthalmology. 2005 Dec;112(12):2070-5. doi: 10.1016/j.ophtha.2005.06.034. Epub 2005 Oct 12. Ophthalmology. 2005. PMID: 16225928 Clinical Trial.

8

Time course and morphology of vascular effects associated with photodynamic therapy.

Schmidt-Erfurth U, Niemeyer M, Geitzenauer W, Michels S. Schmidt-Erfurth U, et al. Ophthalmology. 2005 Dec;112(12):2061-9. doi: 10.1016/j.ophtha.2005.09.007. Ophthalmology. 2005. PMID: 16325705

9

Topographic angiography and optical coherence tomography: a correlation of imaging characteristics.

Ahlers C, Michels S, Elsner H, Birngruber R, Pruente C, Schmidt-Erfurth U. Ahlers C, et al. Eur J Ophthalmol. 2005 Nov-Dec;15(6):774-81. doi: 10.1177/112067210501500619. Eur J Ophthalmol. 2005. PMID: 16329065

10

Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.

Augustin AJ, Schmidt-Erfurth U. Augustin AJ, et al. Ophthalmology. 2006 Jan;113(1):14-22. doi: 10.1016/j.ophtha.2005.09.002. Epub 2005 Dec 19. Ophthalmology. 2006. PMID: 16360209

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

607 results

Search Page

Filters